4.7 Article

Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients

期刊

NEUROLOGY
卷 61, 期 4, 页码 500-506

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/01.WNL.0000079052.01016.78

关键词

-

资金

  1. NIA NIH HHS [U01 AG006786, AG16574, AG19142, R01 AG019142-06, R01 AG019142, U01 AG006786-18, P50 AG016574-05, P50 AG016574, AG06786] Funding Source: Medline

向作者/读者索取更多资源

Objective: To determine whether an fMRI memory encoding task distinguishes among cognitively normal elderly individuals, patients with mild cognitive impairment (MCI), and patients with early Alzheimer's disease ( AD). Methods: Twenty-nine subjects (11 normal, 9 MCI, 9 AD) were studied with an fMRI memory encoding task. A passive sensory task was also performed to assess potential intergroup differences in fMRI responsiveness. Activation in the medial temporal lobe for the memory task and in the anatomic rolandic area for the sensory task was studied. Intergroup comparisons were performed using receiver operating characteristic (ROC) analyses. The ROC method provides rigorous control of artifactual false-positive activation. Subjects were tested for recall and recognition of the encoding task stimuli following the fMRI study. Results: Medial temporal lobe activation was greater in subjects than MCI and AD patients (p = 0.03 and p = 0.04). There was no difference between AD and MCI patients in normal fMRI memory performance. There was an association between fMRI memory activation ( area under the ROC curve) and post-fMRI performance on recognition and free recall. There was no difference among the three groups on the sensory task. Conclusions: MCI and AD patients had less medial temporal lobe activation on the memory task than the normal subjects but similar activation as normal subjects on the sensory task. These findings suggest decreased medial temporal activation may be a specific marker of limbic dysfunction due to the neurodegenerative changes of AD. In addition, fMRI is sufficiently sensitive to detect changes in the prodromal, MCI, phase of the disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据